69862-1
Exclusion criteria - assays PhenX
Trial
66177-7 Do you have hemophilia?
Form Coding Instructions
If respondent answers Yes, they are excluded from phlebotomy
Source: Consensus measures for Phenotypes and ExposuresFully-Specified Name
- Component
- Hemophilia
- Property
- Hx
- Time
- Pt
- System
- ^Patient
- Scale
- Ord
- Method
Additional Names
- Short Name
- Hx of Hemophilia
Basic Attributes
- Class
- H&P.HX
- Type
- Clinical
- First Released
- Version 2.36
- Last Updated
- Version 2.67
- Change Reason
- Release 2.67: METHOD_TYP: This term was created for a PhenX variable but is a general concept that is not specific to PhenX.; Previous Releases: Updated the PhenX ID from "PhenX.<ID>" to "PX<ID>" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.
Survey Question
- Text
- Do you have hemophilia?
- Source
- PX140801060000
Example Answer List LL988-7
| Answer | Code | Score | Answer ID |
|---|---|---|---|
| Yes Copyright http://snomed.info/sct ID:373066001 Yes (qualifier value) | 1 | LA33-6 | |
| No Copyright http://snomed.info/sct ID:373067005 No (qualifier value) | 2 | LA32-8 | |
| Refused | 7 | LA4389-8 | |
| Don't know Copyright http://snomed.info/sct ID:456791000124100 Do not know (qualifier value) | 9 | LA12688-0 |
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 95405-7 | Assay related variables panel [PhenX] |
| 93340-8 | PhenX - complete blood count protocol 220501 |
| 62787-7 | PhenX domain - Diabetes |
| 62949-3 | PhenX domain - Gastrointestinal |
| 62863-6 | PhenX domain - Infectious diseases and immunity |
| 62896-6 | PhenX domain - Skin, bone, muscle and joint |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-MX | Spanish (Mexico) | Hemofilia: |
| it-IT | Italian (Italy) | Emofilia: Synonyms: Anamnesi paziente Punto nel tempo (episodio) Storia; |
| ru-RU | Russian (Russian Federation) | У Вас есть гемофилия: Synonyms: История Порядковый Точка во времени; |
| zh-CN | Chinese (China) | 您是否患有血友病: Synonyms: 依次型; |
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.
66178-5 Have you received cancer chemotherapy in the past four weeks or do you anticipate such therapy in the next four weeks?
Form Coding Instructions
If respondent answers Yes, they are excluded from phlebotomy
Source: Consensus measures for Phenotypes and ExposuresFully-Specified Name
- Component
- Cancer chemotherapy received in the past 4W or will be received in the next 4W
- Property
- Find
- Time
- Pt
- System
- ^Patient
- Scale
- Ord
- Method
Additional Names
- Short Name
- Chemotherapy rcvd past 4W or next 4W
Basic Attributes
- Class
- ONCOLOGY
- Type
- Clinical
- First Released
- Version 2.36
- Last Updated
- Version 2.68
- Change Reason
- Release 2.68: COMPONENT: Updated Component name to represent the clinical concept rather than the specific question from the original source since the question asked will vary across forms and assessments.; CLASS: Moved term to the more representative Class for this concept.; METHOD_TYP: Removed Method of "PhenX" since this is a general concept not specific to PhenX and can be applied to various use cases.; Previous Releases: Updated the PhenX ID from "PhenX.<ID>" to "PX<ID>" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.
Survey Question
- Text
- Have you received cancer chemotherapy in the past four weeks or do you anticipate such therapy in the next four weeks?
- Source
- PX140801070000
Example Answer List LL988-7
| Answer | Code | Score | Answer ID |
|---|---|---|---|
| Yes Copyright http://snomed.info/sct ID:373066001 Yes (qualifier value) | 1 | LA33-6 | |
| No Copyright http://snomed.info/sct ID:373067005 No (qualifier value) | 2 | LA32-8 | |
| Refused | 7 | LA4389-8 | |
| Don't know Copyright http://snomed.info/sct ID:456791000124100 Do not know (qualifier value) | 9 | LA12688-0 |
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 95405-7 | Assay related variables panel [PhenX] |
| 93340-8 | PhenX - complete blood count protocol 220501 |
| 62787-7 | PhenX domain - Diabetes |
| 62949-3 | PhenX domain - Gastrointestinal |
| 62863-6 | PhenX domain - Infectious diseases and immunity |
| 62896-6 | PhenX domain - Skin, bone, muscle and joint |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-MX | Spanish (Mexico) | La quimioterapia contra el cáncer recibida en las últimas 4 semanas o se recibirá en las próximas 4 semanas: |
| it-IT | Italian (Italy) | Ha fatto la chemioterapia per il cancro nelle ultime 4 settimane o prevede tale terapia nelle prossime 4 settimane: Synonyms: Oncologia Osservazione paziente Punto nel tempo (episodio) |
| ru-RU | Russian (Russian Federation) | Вы получали химиотерапию от рака в прошедшие 4 недели или ожидаете подобную терапию в следующие 4 недели: Synonyms: Порядковый Точка во времени; |
| zh-CN | Chinese (China) | 是否已经在过去的那4星期当中接受过癌症化学疗法， Synonyms: 依次型; |
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.